Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Amortizatization of Intangibles of $179000.0 in Q1 2026, up 110.69% quarter-over-quarter from -$1.7 million in Q4 2025, and up 139.34% on a YoY basis from $74788.8 in Q1 2025.
Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Abeona Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $179000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 139.34% year-over-year to $179000.0; the TTM figure through Mar 2026 stood at -$255000.0 (down 165.55% YoY), while the FY2025 annual figure was -$889000.0, down 198.45% from the prior year.
- Amortizatization of Intangibles was $179000.0 for Q1 2026 at Abeona Therapeutics, up from -$1.7 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $960000.0 in Q2 2025 to a low of -$1.7 million in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $87235.3 across 5 years, with a median of $174000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Amortizatization of Intangibles sank 7030.0% in 2022, then surged 13614.29% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $174000.0 in 2022, then surged by 32.18% to $230000.0 in 2023, then soared by 316.09% to $957000.0 in 2024, then slumped by 274.92% to -$1.7 million in 2025, then jumped by 110.69% to $179000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $179000.0 (Q1 2026), -$1.7 million (Q4 2025), and $280000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | 179,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179,000.00 |
| Mar 31, 2026 | 179,000.00 |
| Dec 31, 2025 | -1.67 Mn |
| Dec 31, 2025 | -1.67 Mn |
| Sep 30, 2025 | 280,000.00 |
| Sep 30, 2025 | 280,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Mar 31, 2025 | -455,000.00 |
| Mar 31, 2025 | -455,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Sep 30, 2024 | -120,000.00 |
| Sep 30, 2024 | -120,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Dec 31, 2023 | 230,000.00 |